Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Virotherapy
100%
Recurrent Ovarian Cancer
100%
Measles
100%
Ovarian Cancer
100%
Measles Virus
87%
Antitumor Activity
50%
Cyclophosphamide
37%
Cell Carrier
37%
Virus-infected Cell
25%
Intraperitoneal Administration
25%
Phase I Trial
25%
VsCEP
25%
Vaccine Strain
25%
Cancer Mortality
25%
Virus Strains
25%
Antitumor Properties
25%
Radiovirotherapy
25%
Most Common Cause
25%
Tumor Cells
25%
Gynecological Cancer
25%
Phase 1 Trial
25%
Efficiency Improvement
12%
Human Sodium Iodide Symporter (hNIS)
12%
Membrane Fusion
12%
Cancer Cell Lines
12%
CD46
12%
Viral Monitoring
12%
Intravenous Delivery
12%
Novel Antitumor Agents
12%
Intraperitoneal Delivery
12%
Biologic Activity
12%
Ovarian Cancer Patients
12%
Ovarian Cancer Cells
12%
Therapeutic Transgene
12%
Dismal Prognosis
12%
Heavily Pretreated Patients
12%
Disease Stabilization
12%
MV-NIS
12%
Cell Infection
12%
Neighboring Cells
12%
Tumor-specific
12%
Viral Replication
12%
Cancer Xenograft
12%
Immunosuppressive Drugs
12%
Carcinoembryonic Antigen
12%
Recurrent Disease
12%
Translational Potential
12%
Viral Delivery
12%
Virus Receptor
12%
Carbohydrate Antigen 125 (CA125)
12%
Cell Testing
12%
Virus
12%
Syncytia Formation
12%
Grant Proposal
12%
Viral Distribution
12%
Specific Aims
12%
Novel Therapeutics
12%
Immunomodulatory Properties
12%
Infected Cells
12%
Added Benefit
12%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
100%
Measles
100%
Virotherapy
100%
Carcinoembryonic Antigen
38%
Measles Virus
38%
Antitumor Activity
30%
Cyclophosphamide
23%
Virus
23%
Neoplasm
23%
Vaccine Strain
15%
Female Genital Tract Cancer
15%
Immunosuppressive Agent
15%
Virus Strain
15%
Cancer Mortality
15%
Measles Vaccine
15%
Anticarcinogen
7%
Clinical Trial
7%
Sodium Iodide Symporter
7%
Phase I Trials
7%
Membrane Cofactor Protein
7%
Biological Product
7%
Virus Receptor
7%
Recurrent Disease
7%
Diseases
7%
Infection
7%